熱門資訊> 正文
Prime Medical在定价1.254亿美元股票发行后股价下跌
2025-07-31 11:51
- Prime Medicine (NASDAQ:PRME) has priced its public offering of 38 million shares at $3.30 each, aiming to raise about $125.4 million before expenses.
- The company has also given underwriters a 30-day option to buy up to 5.7 million more shares.
- Notably, the underwriters will not receive any discounts or commissions with respect to 1.81M shares sold to the Cystic Fibrosis Foundation.
- All shares are being sold by Prime Medicine, and the offering is expected to close around August 1, 2025, pending standard conditions.
- PRME --10.97% after hours to $3.49
- Source: Press Release
More on Prime Medicine
- Prime Medicine: Pressing Forward With Lead Liver Targeting Indications
- Prime Medicine soars as Jones sees it as an acquisition target
- RFK Jr. looks to fast track rare disease drug approvals (updated)
- Seeking Alpha’s Quant Rating on Prime Medicine
- Historical earnings data for Prime Medicine
推薦文章
風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。
